Results 61 to 70 of about 190,081 (230)

Обзор материалов симпозиума по урологическим опухолям Американского общества клинической онкологии (ASCO-GU) 2019 г. [PDF]

, 2019
Annual Genitourinary cancers symposium of the American society of clinical oncology (ASCO GU 2019) took place between 14th and 16th February in San Francisco (CA, USA) united more than 4,500professionals from 65 countries.
A. A. Kirichek, А. А. Киричек
core   +1 more source

Understanding Barriers to Clinical Cancer Research in the Asia-Pacific

JCO Global Oncology
PURPOSEDespite the large cancer burden in the Asia-Pacific (APAC) region, there are significant challenges in conducting clinical research for health care professionals (HCPs) in the region, with gross disparities in access to clinical trials for ...
Rashid N. Lui, Jimmy Billod, Sophia Frentzas, Hang Hoang, Vanessa Eaton, Xiudong Jennifer Lei, Elizabeth Garrett-Mayer, David Goldstein, Rebecca Dent, Melvin L. K. Chua   +9 more
doaj   +1 more source

Inflammatory Markers‐Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To explore the predictive value of blood routine parameters for surgical pathological complete response (PCR) following neoadjuvant immunotherapy combined with chemotherapy (NICC) in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Yu‐Dong Ning, Yi‐Xuan Song, Han Li, Yu‐Qin He, Shao‐Yan Liu   +4 more
wiley   +1 more source

Highlights of ASCO 2024

The Oncologist
Highlights from the ASCO annual meeting are presented.
Alfred I Neugut, Susan E Bates
openaire   +2 more sources

Adoption of Hypofractionated Radiation Therapy and Quality of Life Outcomes for Localised Prostate Cancer in an Australian Population‐Based Cohort

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Objectives We aimed to evaluate the adoption of hypofractionated radiotherapy (HFRT) for localised prostate cancer (PCa) and the quality of life (QOL) outcomes at a population‐based level in Victoria. Methods This is a population‐based cohort of individuals with PCa registered in the Victorian Prostate Cancer Outcomes Registry (PCOR‐Vic) who ...
Therese Min Jung Kang, Diane Laura Lim, Sunwoo Kim, David Chang, Sarat Chander, Michael Ng, Jonathan Tomaszewski, Jonathan Bensley, Michelle Steeper, Krupa Krishnaprasad, Maggie Johnson, Nikolajs Zeps, Jeremy Millar, Wee Loon Ong   +13 more
wiley   +1 more source

Competitive funding strategies for the conquer cancer foundation of ASCO

, 2017
PURPOSE: The Conquer Cancer Foundation (CCF), the philanthropic arm of ASCO, is responsible for funding innovative clinical research. CCF wants to broaden its donor base instead of relying predominantly on health-care companies.
Von Roenn, Jamie, Bekaii-Saab, Tanios, Sanjay Goel, Anne S. Tsao, Tanios Bekaii-Saab, Tsao, Anne S, Thompson, Michael A, Dickerson, Adrien, Jamie Von Roenn, Goel, Sanjay, Michael A. Thompson, Adrien Dickerson   +11 more
core   +1 more source

ASCO Resource-Stratified Guidelines: Methods and Opportunities

Journal of Global Oncology, 2018
The objectives of this article are to describe the ASCO Resource-Stratified Guidelines and to provide background within the context of ASCO Guidelines and efforts to address the global cancer burden.
Sana Al-Sukhun, Sarah Temin, Mariana Chavez-MacGregor, Neelima Denduluri, Thomas K. Oliver, Doug Pyle, Manish A. Shah, Julie Gralow   +7 more
doaj   +1 more source

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma [PDF]

Journal of Pathology and Translational Medicine, 2016
Background Human epidermal growth factor receptor 2 (HER2) is one of the known oncogenes in urothelial carcinoma. However, the association between HER2 and the prognosis of upper urinary tract urothelial carcinoma (UUTUC) has not yet been fully clarified.
Gilhyang Kim, Yul Ri Chung, Bohyun Kim, Boram Song, Kyung Chul Moon   +4 more
doaj   +1 more source

Linear Accelerator–Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single‐Institution Cohort Study

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Background Stereotactic body radiotherapy has become an established treatment option for localised prostate cancer. However, real‐world evidence from routine clinical practice remains limited, particularly in cohorts that include older patients.
Atsuto Katano, Hideomi Yamashita
wiley   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source